Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease.

MLA

Wessels, Alette M., et al. “Cognitive Outcomes in Trials of Two BACE Inhibitors in Alzheimer’s Disease.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 16, no. 11, Nov. 2020, pp. 1483–92. EBSCOhost, https://doi.org/10.1002/alz.12164.

APA

Wessels, A. M., Lines, C., Stern, R. A., Kost, J., Voss, T., Mozley, L. H., Furtek, C., Mukai, Y., Aisen, P. S., Cummings, J. L., Tariot, P. N., Vellas, B., Dupre, N., Randolph, C., Michelson, D., Andersen, S. W., Shering, C., Sims, J. R., & Egan, M. F. (2020). Cognitive outcomes in trials of two BACE inhibitors in Alzheimer’s disease. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 16(11), 1483–1492. https://doi.org/10.1002/alz.12164

Chicago

Wessels, Alette M., Christopher Lines, Robert A. Stern, James Kost, Tiffini Voss, Lyn Harper Mozley, Christine Furtek, et al. 2020. “Cognitive Outcomes in Trials of Two BACE Inhibitors in Alzheimer’s Disease.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 16 (11): 1483–92. doi:10.1002/alz.12164.